|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
BR9405507A
(pt)
|
1993-07-13 |
1999-05-25 |
Rhone Poulenc Rorer Sa |
Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica
|
|
EP1012236A1
(en)
|
1997-08-15 |
2000-06-28 |
Rubicon Laboratory Inc. |
Retrovirus and viral vectors
|
|
US6399383B1
(en)
|
1997-10-28 |
2002-06-04 |
Maxygen, Inc. |
Human papilloma virus vectors
|
|
ATE286138T1
(de)
|
1998-03-20 |
2005-01-15 |
Univ Pennsylvania |
Zusammensetzungen und verfahren zur helfer-freien herstellung von rekombinante adeno-assoziierten viren
|
|
WO2000018240A1
(en)
|
1998-10-01 |
2000-04-06 |
University Of Southern California |
Gene delivery system and methods of use
|
|
US6156514A
(en)
|
1998-12-03 |
2000-12-05 |
Sunol Molecular Corporation |
Methods for making recombinant cells
|
|
US6410013B1
(en)
*
|
1999-01-25 |
2002-06-25 |
Musc Foundation For Research Development |
Viral vectors for use in monitoring HIV drug resistance
|
|
WO2000072886A1
(en)
|
1999-05-26 |
2000-12-07 |
Dana-Farber Cancer Institute, Inc. |
Episomally replicating lentiviral vectors
|
|
US7125705B2
(en)
|
2000-04-28 |
2006-10-24 |
Genzyme Corporation |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
WO2001087350A2
(en)
|
2000-05-12 |
2001-11-22 |
The Regents Of The University Of California |
Treatment of human papillomavirus (hpv)-infected cells
|
|
AU2001265187A1
(en)
|
2000-05-30 |
2001-12-11 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
|
NO314588B1
(no)
|
2000-09-04 |
2003-04-14 |
Bionor Immuno As |
HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
|
|
US7122181B2
(en)
|
2000-12-19 |
2006-10-17 |
Research Development Foundation |
Lentiviral vector-mediated gene transfer and uses thereof
|
|
US20030119770A1
(en)
|
2001-08-02 |
2003-06-26 |
Zhennan Lai |
Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
|
|
WO2003015708A2
(en)
*
|
2001-08-18 |
2003-02-27 |
Myriad Genetics, Inc |
Composition and method for treating hiv infection
|
|
US7737124B2
(en)
|
2001-09-13 |
2010-06-15 |
California Institute Of Technology |
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
|
|
US20070203333A1
(en)
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
|
WO2003079757A2
(en)
|
2002-03-20 |
2003-10-02 |
Massachusetts Institute Of Technology |
Hiv therapeutic
|
|
WO2003093436A2
(en)
|
2002-04-30 |
2003-11-13 |
University Of Florida |
Treatment for phenylketonuria
|
|
US20040161412A1
(en)
|
2002-08-22 |
2004-08-19 |
The Cleveland Clinic Foundation |
Cell-based VEGF delivery
|
|
AU2003265948B8
(en)
|
2002-09-06 |
2009-09-03 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
|
|
ATE443764T1
(de)
|
2002-11-04 |
2009-10-15 |
Univ Massachusetts |
Allelspezifische rna-interferenz
|
|
WO2004053137A2
(en)
|
2002-12-11 |
2004-06-24 |
Cytos Biotechnology Ag |
Method for protein production
|
|
EP1627231A2
(en)
|
2003-05-23 |
2006-02-22 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Improvements to gamma delta t cell-mediated therapy
|
|
WO2005005644A1
(en)
|
2003-07-11 |
2005-01-20 |
Cytos Biotechnology Ag |
Gene expression system
|
|
US20050019927A1
(en)
|
2003-07-13 |
2005-01-27 |
Markus Hildinger |
DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER
|
|
US20050138677A1
(en)
|
2003-09-16 |
2005-06-23 |
Pfister Herbert J. |
Transgenic animal model for the treatment of skin tumors
|
|
US20070275010A1
(en)
|
2003-09-18 |
2007-11-29 |
Mark Feinberg |
Mva Vaccines
|
|
WO2005033282A2
(en)
|
2003-10-01 |
2005-04-14 |
Pharmacia & Upjohn Company Llc |
Polyamide compositions and therapeutic methods for treatment of human papilloma virus
|
|
US20080039413A1
(en)
|
2003-10-21 |
2008-02-14 |
Morris David W |
Novel compositions and methods in cancer
|
|
CA2557500C
(en)
|
2004-02-25 |
2016-09-06 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for the treatment and prevention of hiv infection using trim5.alpha.
|
|
US20060058255A1
(en)
|
2004-03-01 |
2006-03-16 |
Jianzhu Chen |
RNAi-based therapeutics for allergic rhinitis and asthma
|
|
TWI439284B
(zh)
|
2004-04-09 |
2014-06-01 |
Abbvie Biotechnology Ltd |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
WO2005118802A2
(en)
|
2004-06-03 |
2005-12-15 |
The Regents Of The University Of California |
Targeting pseudotyped retroviral vectors
|
|
WO2006012221A2
(en)
|
2004-06-25 |
2006-02-02 |
The Regents Of The University Of California |
Target cell-specific short interfering rna and methods of use thereof
|
|
EP1789447B1
(en)
|
2004-08-16 |
2012-04-25 |
Immune Disease Institute, Inc. |
Method of delivering rna interference and uses thereof
|
|
WO2006039721A2
(en)
|
2004-10-08 |
2006-04-13 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
|
|
EP1647595A1
(en)
|
2004-10-15 |
2006-04-19 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Nucleic acids against viruses, in particular HIV
|
|
WO2006048215A1
(en)
|
2004-11-02 |
2006-05-11 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof
|
|
US7790446B2
(en)
|
2005-02-11 |
2010-09-07 |
Kosagen Cell Factory Oü |
Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
|
|
CA2597928A1
(en)
|
2005-02-16 |
2006-08-24 |
Lentigen Corporation |
Lentiviral vectors and their use
|
|
SI2002003T1
(sl)
|
2005-05-27 |
2016-05-31 |
Ospedale San Raffaele S.R.L. |
Genski vektor, ki vsebuje mi-RNA
|
|
US20070032443A1
(en)
|
2005-08-02 |
2007-02-08 |
Jaeseob Kim |
Therapy for Alzheimer's disease
|
|
WO2007015122A1
(en)
|
2005-08-02 |
2007-02-08 |
Genexel, Inc. |
Therapy for alzheimer’s disease
|
|
WO2007056388A2
(en)
|
2005-11-07 |
2007-05-18 |
The General Hospital Corporation |
Compositions and methods for modulating poly (adp-ribose) polymerase activity
|
|
WO2007133674A2
(en)
|
2006-05-12 |
2007-11-22 |
Lentigen Corporation |
Lentiviral vector compositions, methods and applications
|
|
WO2007149476A2
(en)
|
2006-06-19 |
2007-12-27 |
Trustees Of Columbia University In The City Of New York |
Assays for non-apoptotic cell death and uses thereof
|
|
US20080003225A1
(en)
|
2006-06-29 |
2008-01-03 |
Henri Vie |
Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
|
|
WO2008008719A2
(en)
|
2006-07-10 |
2008-01-17 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of the myc gene
|
|
EP1878440A1
(en)
|
2006-07-13 |
2008-01-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
|
|
BRPI0715112A2
(pt)
|
2006-07-26 |
2013-10-01 |
Novartis Ag |
inibidores de undecaprenil pirofosfato sintase
|
|
US20080199961A1
(en)
|
2006-08-25 |
2008-08-21 |
Avi Biopharma, Inc. |
ANTISENSE COMPOSITION AND METHOD FOR INHIBITION OF miRNA BIOGENESIS
|
|
US20090098529A1
(en)
|
2006-10-16 |
2009-04-16 |
Nanhai Chen |
Methods for attenuating virus strains for diagnostic and therapeutic uses
|
|
EP2126137B1
(en)
|
2007-01-23 |
2017-06-07 |
Janssen Pharmaceutica NV |
Method for designing a drug regime for hiv-infected patients
|
|
CN101679466A
(zh)
|
2007-04-12 |
2010-03-24 |
伊利诺伊大学评议会 |
对包括fpps、ggpps和dpps在内的多靶点效力提高的二膦酸盐化合物及方法
|
|
US20080293142A1
(en)
|
2007-04-19 |
2008-11-27 |
The Board Of Regents For Oklahoma State University |
Multiple shRNA Expression Vectors and Methods of Construction
|
|
JP2010528613A
(ja)
*
|
2007-05-29 |
2010-08-26 |
クリストファー ビー． リード， |
多能細胞集団を産生する方法およびその使用
|
|
EP2008656A1
(en)
|
2007-06-28 |
2008-12-31 |
Bergen Teknologioverforing AS |
Compositions for the treatment of hyperphenylalaninemia
|
|
US20110177155A1
(en)
|
2007-08-21 |
2011-07-21 |
Immune Disease Institute, Inc. |
Methods of delivery of agents to leukocytes and endothelial cells
|
|
EP2090659A1
(en)
*
|
2008-02-14 |
2009-08-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Infectious particle, process for its preparation and use thereof
|
|
GB0802754D0
(en)
*
|
2008-02-14 |
2008-03-26 |
Inst Superiore Di Sanito |
Antisense RNA targetting CXCR4
|
|
WO2009120947A1
(en)
|
2008-03-28 |
2009-10-01 |
Virxsys Corporation |
Lentivirus-based immunogenic vectors
|
|
GB0810209D0
(en)
|
2008-06-04 |
2008-07-09 |
Cambridge Entpr Ltd |
Pluripotency associated epigenetic factor
|
|
US8629334B2
(en)
|
2008-07-16 |
2014-01-14 |
University Of Florida Research Foundation, Inc. |
Viral-based transient-expression vector system for trees
|
|
WO2010022195A2
(en)
|
2008-08-20 |
2010-02-25 |
Virxsys Corporation |
Non-integrating lenti/adeno-associated virus hybrid vector system
|
|
WO2010033722A2
(en)
|
2008-09-17 |
2010-03-25 |
Isogenis, Inc. |
Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
|
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
WO2010051521A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Lentigen Corporation |
Cell therapy product for the treatment of hiv infection
|
|
AU2009308707A1
(en)
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
|
WO2011071476A2
(en)
|
2008-11-14 |
2011-06-16 |
Life Technologies Corporation |
Compositions and methods for engineering cells
|
|
EP2191834A1
(en)
|
2008-11-26 |
2010-06-02 |
Centre National De La Recherche Scientifique (Cnrs) |
Compositions and methods for treating retrovirus infections
|
|
WO2010117974A2
(en)
|
2009-04-09 |
2010-10-14 |
Stemcyte Inc. |
Hiv-resistant stem cells and uses thereof
|
|
EP2419113B1
(en)
|
2009-04-13 |
2017-05-10 |
Apceth GmbH & Co. KG |
Engineered mesenchymal stem cells and method of using same to treat tumors
|
|
US8728458B2
(en)
|
2009-04-30 |
2014-05-20 |
The Regents Of The University Of California |
Combination anti-HIV vectors, targeting vectors, and methods of use
|
|
JP5828838B2
(ja)
*
|
2009-07-15 |
2015-12-09 |
カリミューン， インコーポレーティッド |
ヒト免疫不全ウイルス阻害のための二重ベクター
|
|
EA201270108A1
(ru)
|
2009-10-08 |
2012-08-30 |
Бавариан Нордик А/С |
Формирование полиспецифического t-клеточного ответа против вич у человека
|
|
WO2011066578A1
(en)
|
2009-11-30 |
2011-06-03 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
|
CN101805750B
(zh)
|
2009-12-29 |
2011-11-30 |
浙江大学 |
法呢基焦磷酸合成酶rna干扰重组慢病毒载体构建及用途
|
|
WO2011103417A2
(en)
|
2010-02-18 |
2011-08-25 |
Emory University Of Technology Transfer |
Vectors expressing hiv antigens and gm-csf and related methods for generating an immune response
|
|
WO2011119942A1
(en)
|
2010-03-25 |
2011-09-29 |
Vistagen Therapeutics, Inc. |
Induction of ips cells using transient episomal vectors
|
|
US20130090371A1
(en)
|
2010-04-20 |
2013-04-11 |
President And Fellows Of Harvard College |
Methods and compositions for inhibition of beta2-adrenergic receptor degradation
|
|
ES2699630T3
(es)
|
2010-04-23 |
2019-02-12 |
Cold Spring Harbor Laboratory |
Novedosos ARNhc diseñados estructuralmente
|
|
WO2011148194A1
(en)
|
2010-05-28 |
2011-12-01 |
Oxford Biomedica (Uk) Ltd |
Delivery of lentiviral vectors to the brain
|
|
US9670459B2
(en)
|
2010-08-10 |
2017-06-06 |
Takara Bio Inc. |
Production method for cell populations
|
|
WO2012048303A2
(en)
|
2010-10-07 |
2012-04-12 |
Columbia University |
METHOD FOR TREATING CANCER HARBORING A p53 MUTATION
|
|
WO2012061075A2
(en)
|
2010-10-25 |
2012-05-10 |
The Regents Of The University Of California |
Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
|
|
CN103492574B
(zh)
|
2011-02-22 |
2015-12-09 |
加州理工学院 |
使用腺相关病毒（aav）载体递送蛋白
|
|
US9226976B2
(en)
|
2011-04-21 |
2016-01-05 |
University Of Massachusetts |
RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
US10640785B2
(en)
|
2011-11-22 |
2020-05-05 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
US9745631B2
(en)
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
|
SG10201609345QA
(en)
|
2012-02-07 |
2017-01-27 |
Global Bio Therapeutics Inc |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
KR20150029678A
(ko)
*
|
2012-06-06 |
2015-03-18 |
바이오노르 이뮤노 에이에스 |
백신
|
|
CA2879514C
(en)
|
2012-07-17 |
2020-04-14 |
Universite De Geneve |
Nucleic acids for down-regulation of gene expression
|
|
WO2014052855A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
|
WO2014076137A1
(en)
|
2012-11-13 |
2014-05-22 |
Lötvall Jan |
Delivery of therapeutic agent
|
|
EP2929017A4
(en)
|
2012-12-05 |
2016-09-28 |
Sangamo Biosciences Inc |
METHOD AND COMPOSITIONS FOR REGULATING METABOLISM DISEASES
|
|
US9642921B2
(en)
|
2012-12-20 |
2017-05-09 |
Tocagen Inc. |
Cancer combination therapy and recombinant vectors
|
|
WO2014117050A2
(en)
|
2013-01-26 |
2014-07-31 |
Mirimus, Inc. |
Modified mirna as a scaffold for shrna
|
|
CN103184224A
(zh)
|
2013-04-03 |
2013-07-03 |
衡阳师范学院 |
一种抗艾滋病病毒感染的三联miRNA及构建方法
|
|
WO2014187881A1
(en)
|
2013-05-21 |
2014-11-27 |
Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. |
Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy
|
|
AU2014296059B2
(en)
*
|
2013-08-02 |
2020-12-10 |
The Regents Of The University Of California |
Engineering antiviral T cell immunity through stem cells and chimeric antigen receptors
|
|
WO2015042308A2
(en)
|
2013-09-18 |
2015-03-26 |
City Of Hope |
Rna-based hiv inhibitors
|
|
MX2016005239A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Tratamiento con acido ribonucleico mensajero para la fenilcetonuria.
|
|
CA2930015A1
(en)
|
2013-11-07 |
2015-05-14 |
Editas Medicine, Inc. |
Crispr-related methods and compositions with governing grnas
|
|
EP2878674A1
(en)
|
2013-11-28 |
2015-06-03 |
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) |
Stable episomes based on non-integrative lentiviral vectors
|
|
GB201322091D0
(en)
|
2013-12-13 |
2014-01-29 |
Cambridge Entpr Ltd |
Modified serpins for the treatment of bleeding disorders
|
|
AU2015249554B2
(en)
|
2014-04-23 |
2021-08-19 |
Juno Therapeutics, Inc. |
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
|
|
PL3851537T3
(pl)
|
2014-04-25 |
2024-09-16 |
Genethon |
Leczenie hiperbilirubinemii
|
|
SMT202100700T1
(it)
|
2014-04-25 |
2022-01-10 |
2Seventy Bio Inc |
Recettori antigenici chimerici con promotore mnd
|
|
WO2016033163A1
(en)
|
2014-08-29 |
2016-03-03 |
Immunomedics, Inc. |
Identification of cancer genes by in-vivo fusion of human cancer cells and animal cells
|
|
EP3197472B1
(en)
|
2014-09-22 |
2021-08-04 |
Tanea Medical AB |
Recombinant phe-free proteins for use in the treatment of phenylketonuria
|
|
MA40783A
(fr)
|
2014-10-03 |
2017-08-08 |
Los Alamos Nat Security Llc |
Vaccins contre le vih comprenant un ou plusieurs antigènes episensus de population
|
|
US11053314B2
(en)
|
2014-10-10 |
2021-07-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods to eliminate cancer stem cells by targeting CD47
|
|
CN107405357B
(zh)
*
|
2014-10-14 |
2021-12-31 |
德克萨斯科技大学系统 |
多重shRNAs及其应用
|
|
WO2016069521A1
(en)
|
2014-10-27 |
2016-05-06 |
International Aids Vaccine Initiative |
Optimized hiv envelope gene and expression thereof
|
|
WO2016069716A1
(en)
|
2014-10-30 |
2016-05-06 |
The Scripps Research Institute |
Compositions and methods comprising tyrosyl-trna synthetases and resveratrol compounds
|
|
HK1247963A1
(zh)
|
2015-05-18 |
2018-10-05 |
Csl贝林基因治疗股份有限公司 |
用於hiv的治疗的基因疗法及其用途
|
|
GB201509202D0
(en)
|
2015-05-28 |
2015-07-15 |
Ge Healthcare Bio Sciences Ab |
Semi-static cell culture
|
|
US20180161455A1
(en)
|
2015-06-10 |
2018-06-14 |
American Gene Technologies International, Inc. |
Non-integrating viral delivery system and methods of use therof
|
|
JP6890831B2
(ja)
|
2015-07-08 |
2021-06-18 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
Ｈｉｖ予備免疫化および免疫療法
|
|
JP6780870B2
(ja)
|
2015-08-13 |
2020-11-04 |
北昊干細胞与再生医学研究院有限公司Ｂｅｉｈａｏ Ｓｔｅｍ Ｃｅｌｌ Ａｎｄ Ｒｅｇｅｎｅｒａｔｉｖｅ Ｍｅｄｉｃｉｎｅ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ｃｏ．， Ｌｔｄ． |
誘導された拡張された多能性幹細胞、作製方法および使用方法
|
|
CN105112370B
(zh)
|
2015-08-25 |
2019-02-05 |
杭州优善生物科技有限公司 |
一种体外刺激外周血γδT细胞高效增殖的方法及其应用
|
|
JP7059179B2
(ja)
|
2015-10-20 |
2022-04-25 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
遺伝子操作のための方法及び製品
|
|
US11389546B2
(en)
|
2015-12-09 |
2022-07-19 |
Modernatx, Inc. |
Heterologous UTR sequences for enhanced mRNA expression
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
AU2017207906B2
(en)
|
2016-01-15 |
2021-03-11 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
WO2017139065A1
(en)
|
2016-02-08 |
2017-08-17 |
American Gene Technologies International Inc. |
Hiv vaccination and immunotherapy
|
|
WO2017156311A2
(en)
|
2016-03-09 |
2017-09-14 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
|
US20190117799A1
(en)
|
2016-04-01 |
2019-04-25 |
The Brigham And Women's Hospital, Inc. |
Stimuli-responsive nanoparticles for biomedical applications
|
|
WO2017213697A1
(en)
|
2016-06-08 |
2017-12-14 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
WO2018009246A1
(en)
|
2016-07-08 |
2018-01-11 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
EP3487507A4
(en)
|
2016-07-21 |
2020-04-08 |
American Gene Technologies International, Inc. |
VIRAL VECTORS FOR THE TREATMENT OF PARKINSON'S DISEASE
|
|
JP6923215B2
(ja)
|
2016-08-03 |
2021-08-18 |
国立大学法人 鹿児島大学 |
抗ｈｔｌｖ−１剤、ｈｔｌｖ−１関連脊髄症（ｈａｍ／ｔｓｐ）治療薬
|
|
MX2019007876A
(es)
|
2016-12-30 |
2019-10-15 |
Univ Pennsylvania |
Terapia genetica para tratar fenilcetonuria.
|
|
BR112019014082A2
(pt)
|
2017-01-09 |
2020-03-03 |
American Gene Technologies International Inc. |
Imunoterapia para hiv sem etapa de pré-imunização
|
|
CN110621322A
(zh)
|
2017-02-08 |
2019-12-27 |
达纳-法伯癌症研究所有限公司 |
用异双功能性化合物进行的可调节的内源性蛋白质降解
|
|
US11820999B2
(en)
|
2017-04-03 |
2023-11-21 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
KR20200018586A
(ko)
|
2017-06-16 |
2020-02-19 |
아메리칸 진 테크놀로지스 인터내셔널 인코포레이티드 |
인간 감마-델타 t-세포를 통한 종양 세포독성의 활성화를 위한 방법 및 조성물
|
|
EP3692157A4
(en)
|
2017-10-02 |
2021-06-23 |
American Gene Technologies International Inc. |
VECTORS INCLUDING COMBINATIONS OF PROMOTER AND ACTIVATOR FOR PHENYLKETONURIS TREATMENT
|
|
JP2022506515A
(ja)
|
2018-11-05 |
2022-01-17 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
制御性ｒｎａを発現させるためのベクターシステム
|
|
BR112021024124A2
(pt)
|
2019-05-31 |
2022-01-11 |
American Gene Tech Int Inc |
Expressão otimizada de fenilalanina hidroxilase
|